{"id":"W2146959803","doi":"10.1016/j.jmoldx.2013.04.007","title":"BCR-ABL1 RT-qPCR for Monitoring the Molecular Response to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia","year":2013,"lang":"en","type":"review","venue":"Journal of Molecular Diagnostics","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"ca_institutions":"University Health Network","funders":"Novartis Pharmaceuticals Corporation; Ariad Pharmaceuticals; Bristol-Myers Squibb","keywords":"Dasatinib; Nilotinib; Bosutinib; Myeloid leukemia; Tyrosine kinase; Imatinib; Tyrosine-kinase inhibitor; Cancer research; Imatinib mesylate; Ponatinib; Bruton's tyrosine kinase; ABL; Medicine; Fusion gene; Biology; Internal medicine; Genetics; Cancer; Gene","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001367101,0.001139069,0.002115324,0.001989729,0.0001662527,0.0008998485,0.001245783,0.001056755,0.001856794],"category_scores_gemma":[0.00101082,0.0005151647,0.0008319839,0.001402434,0.0005572307,0.0006648755,0.000391017,0.001868963,0.001459748],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006320743,"about_ca_system_score_gemma":0.0007864143,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009534027,"about_ca_topic_score_gemma":0.00228833,"domain_scores_codex":[0.9994729,0.00008443239,0.00004745782,0.00009951262,0.0002556964,0.00004002993],"domain_scores_gemma":[0.999185,0.0004648418,0.0001242924,0.0000206138,0.000178788,0.00002643867],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000195944,0.0001070382,0.0005554425,0.00831393,0.0001200353,0.00008973449,0.00002905489,0.0004975373,0.01351055,0.0007652671,0.009589248,0.9662262],"study_design_scores_gemma":[0.0001725702,0.00106424,0.01139226,0.00508116,0.001119687,0.003485843,0.0001421891,0.002531778,0.04733456,0.002860781,0.9246547,0.0001602271],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005800675,0.9972981,0.0009523088,0.0001978048,0.0001832416,0.00001475085,0.00005982255,0.00002526397,0.0006887021],"genre_scores_gemma":[0.007790366,0.9873248,0.00235146,0.0004567943,0.0002447734,0.00005724304,0.0001967349,0.000009730392,0.001568074],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002115324,"threshold_uncertainty_score":0.007230043,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02966965881962388,"score_gpt":0.3327350379289139,"score_spread":0.30306537910929,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}